These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35444416)

  • 1. PD-1 Targeted Nanoparticles Inhibit Activated T Cells and Alleviate Autoimmunity via Suppression of Cellular Energy Metabolism Mediated by PKM2.
    Liu Z; Xu J; Li H; Shu J; Su G; Zhou C; Yang P
    Int J Nanomedicine; 2022; 17():1711-1724. PubMed ID: 35444416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of IL-27 Signaling Exacerbates Experimental Autoimmune Uveitis with Elevated Uveitogenic Th1 and Th17 Responses.
    Wu S; Ma R; Zhong Y; Chen Z; Zhou H; Zhou M; Chong W; Chen J
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.
    Luger D; Silver PB; Tang J; Cua D; Chen Z; Iwakura Y; Bowman EP; Sgambellone NM; Chan CC; Caspi RR
    J Exp Med; 2008 Apr; 205(4):799-810. PubMed ID: 18391061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionally distinct IFN-γ
    Chen YH; Eskandarpour M; Gondrand A; Zhang X; Gu R; Galatowicz G; Lightman SL; Calder VL
    Eur J Immunol; 2020 Dec; 50(12):1941-1951. PubMed ID: 32652562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
    Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
    Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological Activation of Pyruvate Kinase M2 Inhibits CD4
    Angiari S; Runtsch MC; Sutton CE; Palsson-McDermott EM; Kelly B; Rana N; Kane H; Papadopoulou G; Pearce EL; Mills KHG; O'Neill LAJ
    Cell Metab; 2020 Feb; 31(2):391-405.e8. PubMed ID: 31761564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KS23, a novel peptide derived from adiponectin, inhibits retinal inflammation and downregulates the proportions of Th1 and Th17 cells during experimental autoimmune uveitis.
    Niu T; Cheng L; Wang H; Zhu S; Yang X; Liu K; Jin H; Xu X
    J Neuroinflammation; 2019 Dec; 16(1):278. PubMed ID: 31883532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The B subunit of Escherichia coli heat-labile enterotoxin inhibits Th1 but not Th17 cell responses in established experimental autoimmune uveoretinitis.
    Raveney BJ; Richards C; Aknin ML; Copland DA; Burton BR; Kerr E; Nicholson LB; Williams NA; Dick AD
    Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4008-17. PubMed ID: 18469197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation.
    Kono M; Maeda K; Stocton-Gavanescu I; Pan W; Umeda M; Katsuyama E; Burbano C; Orite SYK; Vukelic M; Tsokos MG; Yoshida N; Tsokos GC
    JCI Insight; 2019 Jun; 4(12):. PubMed ID: 31217348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory effects of IFN-β on the development of experimental autoimmune uveoretinitis in B10RIII mice.
    Sun M; Yang Y; Yang P; Lei B; Du L; Kijlstra A
    PLoS One; 2011 May; 6(5):e19870. PubMed ID: 21573074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-β inhibits the increased expression of IL-9 during experimental autoimmune uveoretinitis.
    Yang Y; Du L; Sun M; Kijlstra A; Yang P
    PLoS One; 2012; 7(10):e48566. PubMed ID: 23119059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TMP778, a selective inhibitor of RORγt, suppresses experimental autoimmune uveitis development, but affects both Th17 and Th1 cell populations.
    Lyu C; Bing SJ; Wandu WS; Xu B; Shi G; Hinshaw SJ; Lobera M; Caspi RR; Lu L; Yang J; Gery I
    Eur J Immunol; 2018 Nov; 48(11):1810-1816. PubMed ID: 30218573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin, an endogenous hormone, modulates Th17 cells via the reactive-oxygen species/TXNIP/HIF-1α axis to alleviate autoimmune uveitis.
    Huang J; Li Z; Hu Y; Li Z; Xie Y; Huang H; Chen Q; Chen G; Zhu W; Chen Y; Su W; Chen X; Liang D
    J Neuroinflammation; 2022 May; 19(1):124. PubMed ID: 35624485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
    Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
    Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of retinoic acid receptor-alpha/beta-specific ligand Am80 suppresses experimental autoimmune uveoretinitis.
    Keino H; Watanabe T; Sato Y; Okada AA
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1548-56. PubMed ID: 20861477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel IL27p28/IL12p40 cytokine suppressed experimental autoimmune uveitis by inhibiting autoreactive Th1/Th17 cells and promoting expansion of regulatory T cells.
    Wang RX; Yu CR; Mahdi RM; Egwuagu CE
    J Biol Chem; 2012 Oct; 287(43):36012-21. PubMed ID: 22936807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrameric PKM2 Activation Curbs CD4
    Jiang S
    Trends Endocrinol Metab; 2020 Jun; 31(6):393-395. PubMed ID: 32340764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU).
    Vistica BP; Shi G; Nugent L; Tan C; Altman A; Gery I
    Mol Vis; 2012; 18():1858-64. PubMed ID: 22815639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOCS3 deletion in T lymphocytes suppresses development of chronic ocular inflammation via upregulation of CTLA-4 and expansion of regulatory T cells.
    Yu CR; Kim SH; Mahdi RM; Egwuagu CE
    J Immunol; 2013 Nov; 191(10):5036-43. PubMed ID: 24101549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.